All Campaigns
FUNDING CTDA Validated

BioSensor Pro — Wearable Health Monitor

Revolutionary biosensor patent that monitors glucose, cortisol, and inflammation markers in real-time through a non-invasive wearable device.

By Dr. Sarah Chen, PhD Biomedical Engineering

✨ AI Patent Analysis (Gemini)

**Innovation**: Non-invasive continuous glucose monitoring using novel photonic crystal biosensors. **Market Size**: $32B wearable health market, growing 15% YoY. **IP Strength**: 3 granted patents, 2 pending. Broad claims covering method and apparatus. **Risk**: Low-Medium. FDA 510(k) pathway identified.

Milestones & Drip-Release

Prototype Development
25% of funds released
COMPLETED
2
Clinical Trials
25% of funds released
IN PROGRESS
3
Manufacturing Setup
25% of funds released
PENDING
4
First Batch Delivery
25% of funds released
PENDING
$75,000of $120,000
63% funded
234
Investors
$500
Token Price
240
NFT Supply
5,000
Items
Total: $500